Primary preventive cardioverter-defibrillator implantation (Pro-ICD) in patients awaiting heart transplantation. A prospective, randomized, controlled 12-year follow-up study

Transplant International

Volumn 28, Issue 1, 2015, Pages 34-41

  Pezawas, Thomas ^a   Grimm, Michael ^a   Ristl, Robin ^a   Kivaranovic, Danijel ^a   Moser, Fabian T ^a   Laufer, Guenther ^a   Schmidinger, Herwig ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

heart transplantation; implantable cardioverter defibrillator; sudden cardiac death

Indexed keywords

ACUTE HEART FAILURE; ADULT; AEROBIC CAPACITY; AGED; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CLINICAL ARTICLE; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EXERCISE; FEMALE; FOLLOW UP; HEART DEATH; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; KIDNEY FAILURE; MALE; MITRAL VALVE REGURGITATION; OPEN STUDY; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL; SMOKING; SURVIVAL TIME; SURVIVOR; TIME TO TREATMENT; CLINICAL TRIAL; HEART FAILURE; HEART VENTRICLE; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PROPORTIONAL HAZARDS MODEL; SUDDEN CARDIAC DEATH; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

ADULT; AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PILOT PROJECTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84916229854     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12436     Document Type: Article

References (24)

1. Stevenson WG, Stevenson LW, Middlekauff HR, Saxon LA,. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation 1993; 88: 2953.
2. Zipes DP, Camm AJ, Borggrefe M, et al,. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8: 746.
3. Saxon LA, Wiener I, DeLurgio DB, et al,. Implantable defibrillators for high-risk patients with heart failure who are awaiting cardiac transplantation. Am Heart J 1995; 130: 501.
4. Bolling SF, Deeb GM, Morady F, et al,. Automatic internal cardioverter defibrillator: a bridge to heart transplantation. J Heart Lung Transplant 1991; 10: 562.
5. Jeevanandam V, Bielefeld MR, Auteri JS, et al,. The implantable defibrillator: an electronic bridge to cardiac transplantation. Circulation 1992; 5 (Suppl): II276.
6. Moss AJ, Zareba W, Hall WJ, et al,. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877.
7. Bardy GH, Lee KL, Mark DB, et al,. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225.
8. Yang TF, Macfarlane PW,. New sex dependent normal limits of the signal averaged electrocardiogram. Br Heart J 1994; 72: 197.
9. Hinkle LE Jr,. Thaler HT. Clinical classification of cardiac deaths. Circulation 1982; 65: 457.
10. Myerburg RJ, Kessler KM, Castellanos A,. Sudden cardiac death, Structure, function, and time-dependence of risk. Circulation 1992; 1 (Suppl): I2.
11. Epstein AE, DiMarco JP, Ellenbogen KA, et al,. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 51: e1.
12. Bansch D, Antz M, Boczor S, et al,. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 2002; 105: 1453.
13. Strickberger SA, Hummel JD, Bartlett TG, et al,. Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT. J Am Coll Cardiol 2003; 41: 1707.
14. Sandner SE, Wieselthaler G, Zuckermann A, et al,. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation 2001; 104 (12 Suppl 1): I171.
15. Ermis C, Zadeii G, Zhu AX, et al,. Improved survival of cardiac transplantation candidates with implantable cardioverter defibrillator therapy: role of beta-blocker or amiodarone treatment. J Cardiovasc Electrophysiol 2003; 14: 578.
16. Saba S, Atiga WL, Barrington W, et al,. Selected patients listed for cardiac transplantation may benefit from defibrillator implantation regardless of an established indication. J Heart Lung Transplant 2003; 22: 411.
17. Frohlich GM, Holzmeister J, Hubler M, et al,. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation. Heart 2013; 99: 1158.
18. Da Rosa MR, Sapp JL, Howlett JG, Falkenham A, Legare JF,. Implantable cardioverter-defibrillator implantation as a bridge to cardiac transplantation. J Heart Lung Transplant 2007; 26: 1336.
19. van den Broek SA, van Veldhuisen DJ, de Graeff PA, et al,. Mode of death in patients with congestive heart failure: comparison between possible candidates for heart transplantation and patients with less advanced disease. J Heart Lung Transplant 1993; 12: 367.
20. Accardo A, Tesauro D, Roscigno P, et al,. Physicochemical properties of mixed micellar aggregates containing CCK peptides and Gd complexes designed as tumor specific contrast agents in MRI. J Am Chem Soc 2004; 126: 3097.
21. Grigioni F, Boriani G, Barbieri A, et al,. Relevance of cardioverter defibrillators for the prevention of sudden cardiac death on the timing of heart transplantation. Clin Transplant 2006; 20: 684.
22. Bastante Valiente T, Ruiz Cano MJ, Delgado JF, et al,. Defibrillator implantation for the primary prevention of sudden death in patients awaiting cardiac transplantation: one center's experience. Rev Esp Cardiol (Engl Ed) 2011; 64: 240.
23. Sims DB, Garcia LI, Mignatti A, et al,. Utilization of defibrillators and resynchronization therapy at the time of evaluation at a heart failure and cardiac transplantation center. Pacing Clin Electrophysiol 2010; 33: 988.
24. Klein HU, Goldenberg I, Moss AJ,. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Eur Heart J 2013; 34: 2230.